BioTrinity 2016 – 10th Biopartnering Conference

BioTrinity 2016 to be held this year in London, April 25-27, is set to provide a platform for R&D, global pharma and investor companies across the life sciences industry to achieve their business objectives; to secure funding, seek acquisition and in-licensing deals and grow their network. With a full conference programme visitors will also be able to experience networking and pitching sessions, view the latest technologies from exhibiting companies and attend numerous workshops. Poster sessions will also run throughout the event.

Celebrating its 10 year anniversary in April 2016, BioTrinity’s programme incorporates the theme ‘Vision for Life Sciences 2030’. The dedicated MediTrinity stream will also address the ‘Vision for Medtech 2030’. George Freeman MP, Minister for Life Sciences, will open with the keynote presentation exploring the strengths and future challenges for the health and life sciences sectors in the UK.

Latest developments will be discussed in two exciting biotech and medtech focused panels at BioTrinity, involving 13 key senior representatives from leading global life sciences organisations. 'Building Long-Term Value Without an Exit in Mind’ will focus on growth andexploring value creation in the long game. Looking beyond the 10-year LP fund, it will explore the financial and partnering strategy required from the starting-point to safeguard your shot at building a mid-sized biotech and taking your drugs to market.

'How Patient Groups Believe Technology Will Impact Their Experience by 2030?' will enable the audience to learn how patients and patient-facing organisations vision the impact of the change in the use of technology by patients, given the growth in digital health and mobile health technology usage and the explosion in the use of apps in the self-management of health.

For registration details and more information on the conference and exhibiting companies visit www.biotrinity.com